Skip to main content
OpenTrials

Clinical trial condition

Castration-Resistant Prostate Carcinoma

Explore clinical trials studying Castration-Resistant Prostate Carcinoma. Study availability and eligibility vary by location and protocol.

54 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Castration-Resistant Prostate Carcinoma trial results

Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

NCT05828082

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT03517969

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02703623

Conditions
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +12 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details

Related conditions